Evidence map›Paper›PMID 19002158›Full record

ReviewCell research2009

Signaling cross-talk between TGF-beta/BMP and other pathways.

Xing Guo, Xiao-Fan Wang

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 565 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
565citing papers in PubMed, 2 pooled it
19.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

565 citing papers in PubMed, 2 syntheses or guidelines pooled it, 998 citations in OpenAlex.

  1. Pooled it
  2. The Skeletal Effects of Tanshinones: A Review.Molecules (Basel, Switzerland) · 2021
    Pooled it
  3. Review
  4. Bone morphogenetic protein signaling as a key regulator of retinal fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. TGF-β Pathway-Based Polygenic Risk Score Modifies the Association between Red Meat Intake and Colorectal Cancer Risk: Application of a Novel Pathway-Based PRS Method.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. International journal of molecular sciences · 2026
    Article
  15. Review
  16. Review
  17. International journal of molecular sciences · 2026
    Article
  18. Article
  19. Article
  20. Article

505 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xing GuoDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Xiao-Fan Wang
Duke Medical Center · USDuke University Hospital · US

Funding

Mechanisms of TGF-B/Smad SignalingR01GM083000 · NIGMS · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2008 to 2011
$1.2M
TGF-beta Signaling in MSCs and OsteoblastR01DK064113 · NIDDK · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2004 to 2007
$994k
NIDDK NIH HHS DK064113NIDDK NIH HHS R01 DK064113NIGMS NIH HHS GM083000NIGMS NIH HHS R01 GM083000
6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-beta)/bone morphogenic protein (BMP) signaling is involved in the vast majority of cellular processes and is fundamentally important during the entire life of all metazoans. Deregulation of TGF-beta/BMP activity almost invariably leads to developmental defects and/or diseases, including cancer. The proper functioning of the TGF-beta/BMP pathway depends on its constitutive and extensive communication with other signaling pathways, leading to synergistic or antagonistic effects and eventually desirable biological outcomes. The nature of such signaling cross-talk is overwhelmingly complex and highly context-dependent. Here we review the different modes of cross-talk between TGF-beta/BMP and the signaling pathways of Mitogen-activated protein kinase, phosphatidylinositol-3 kinase/Akt, Wnt, Hedgehog, Notch, and the interleukin/interferon-gamma/tumor necrosis factor-alpha cytokines, with an emphasis on the underlying molecular mechanisms.

Indexed as

Receptor Cross-TalkSignal TransductionBone Morphogenetic ProteinsHumansIntercellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemReceptors, Transforming Growth Factor betaTranscription FactorsTransforming Growth Factor betaBone Morphogenetic ProteinsIntercellular Signaling Peptides and ProteinsReceptors, Transforming Growth Factor betaTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID19002158
PMCPMC3606489
OpenAlexW1972429412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.